# Injectable electroconductive Prussian blue nanofiber-PVA hydrogel modulates the wound microenvironment to promote diabetic wound healing

**Authors:** Dian-Qing Wang, Jin Huang, Sheng Chang

PMC · DOI: 10.3389/fbioe.2026.1748784 · Frontiers in Bioengineering and Biotechnology · 2026-02-16

## TL;DR

A new injectable hydrogel with electroconductive properties helps speed up healing in diabetic wounds by improving the wound environment.

## Contribution

The development of an injectable Prussian Blue nanofiber-PVA hydrogel with electroconductive and immunomodulatory properties for diabetic wound healing.

## Key findings

- The hydrogel accelerated wound closure and reduced inflammation in diabetic mice.
- It promoted collagen deposition and increased CD31-positive staining, indicating improved angiogenesis.
- The hydrogel showed cytocompatibility and reduced pro-inflammatory cytokines in vitro.

## Abstract

Chronic diabetic wounds exhibit persistent oxidative stress, prolonged inflammation, impaired angiogenesis, and a disrupted bioelectric microenvironment that hinders re-epithelialization. Here, we develop an injectable Prussian Blue nanofiber-PVA hydrogel (PBM.PVA gel) with electroconductive and immunomodulatory features for accelerated diabetic wound repair. Electrospun PBM nanofibers were uniformly embedded within a physically cross linked PVA matrix, producing a flexible and adhesive composite with stable conductivity. In vitro, PBM. PVA gel showed excellent cytocompatibility, reduced pro-inflammatory cytokines (IL-6, TNF-α, CD86), and enhanced pro-regenerative markers (CD206, CD31). In streptozotocin-induced diabetic mice, the hydrogel significantly accelerated wound closure, reduced inflammatory infiltration, and promoted collagen deposition with increased CD31-positive staining. While PBM has been reported to possess redox-regulatory potential, ROS levels and endogenous wound electrical fields were not directly quantified in this study; therefore, mechanistic interpretations are described as plausible and require further validation. Together, PBM. PVA gel provides a multifunctional dressing that supports a favorable wound microenvironment and improves healing outcomes in diabetic wounds.

## Linked entities

- **Chemicals:** Prussian Blue (PubChem CID 2724251), PVA (PubChem CID 11199), IL-6 (PubChem CID 165368475)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Cd86 (CD86 antigen) [NCBI Gene 12524] {aka B7, B7-2, B7.2, B70, CLS1, Cd28l2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}
- **Diseases:** cytotoxicity (MESH:D064420), hyperglycemic (MESH:D006944), diabetic ulcers (MESH:D017719), skin defects (MESH:D012868), tissue injury (MESH:D017695), Chronic (MESH:D002908), PBM (MESH:D015433), swelling (MESH:D004487), Diabetic wounds (MESH:D003920), inflammation (MESH:D007249), Hemolysis (MESH:D006461), metabolic dysregulation (MESH:D021081), vascular fragility (MESH:D005600), bleeding (MESH:D006470)
- **Chemicals:** PVA hydrogel (MESH:C062364), PVA (MESH:D011142), hematoxylin (MESH:D006416), HFIP (-), aluminum (MESH:D000535), H&amp;E (MESH:D006371), DAPI (MESH:C007293), calcium (MESH:D002118), eosin (MESH:D004801), PB (MESH:D007854), PVDF (MESH:C024865), hydrogen (MESH:D006859), LPS (MESH:D008070), PLA (MESH:C033616), PVA (MESH:C063253), FITC (MESH:D016650), Prussian Blue (MESH:C000170), paraffin (MESH:D010232), saline (MESH:D012965), Au (MESH:D006046), PBM (MESH:C009924), hexafluoroisopropanol (MESH:C001337), PE (MESH:D020959), blood glucose (MESH:D001786), SDS (MESH:D012967), DCFH-DA (MESH:C029569), Fe (MESH:D007501), STZ (MESH:D013311), CCK-8 (MESH:D012844), water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HUVEC — Homo sapiens (Human), Finite cell line (CVCL_2959), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950806/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950806/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950806/full.md

---
Source: https://tomesphere.com/paper/PMC12950806